Return to program book search

Session Information

SYM S062 - Therapeutic Decision Making in Cutaneous Oncology

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Tuesday, March 05

CME Credits: 3.00

Location: Room C220/221/222

Time: 2:00 PM - 5:00 PM

Director: Fiona O'Reilly Zwald, MD, FAAD

Speakers:

  • David R. Bickers, MD, FAAD
  • Marc D. Brown, MD, FAAD
  • Jeffrey Phillip Callen, MD, FAAD - Handout
  • Timothy M. Johnson, MD, FAAD - Handout
  • Nathalie C. Zeitouni, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Recognize the presentation of skin cancer in various clinic scenarios of systemic immunosuppression
  • Formulate a therapeutic strategy for non-surgical treatment of skin cancer utilizing recent drug advances
  • Select the best use for sentinel lymph node biopsy in the management of melanoma

Description:
This symposium addresses the therapeutic challenges of treating high risk skin cancer in the setting of immunocompromise, e.g. solid organ and bone marrow transplantation and with the use of biologic therapies, for both the medical dermatologist and dermatological surgeon. Use of non-surgical interventions, including PDT and recent advances in drug therapies for skin cancer will be outlined. An up-to-date review of sentinel lymph node biopsy and its use in the treatment of melanoma will also be discussed.

References:

  • Zwald F, Brown M. Skin cancer in solid organ transplant recipients, advance in therapy and management. CME review. J Am Acad Dermatol 2012.
  • Sekulic A,l et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012 Jun 7;366(23):2171-9. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. N Engl J Med. 2012 Jun 7;366(23):2171-9. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. N Engl J Med. 2012 Jun 7;366(23):2171-9.
  • Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2012.

Schedule:

Tuesday, March 05
2:00 PMIntroduction and welcome / Dr. Zwald
2:05 PMTherapeutic decision making in cutaneous oncology: the use of Photodynamic therapy / Dr. Zeitouni
2:30 PMNon surgical applications in cutaneous oncology / Dr. Brown
3:00 PMVismodegib As Targeted Mechanism-driven Treatment of Patients with Gorlin Syndrome: What We Have Learned / Dr. Bickers
3:30 PMRisk of Skin Cancer in patients without transplants who take biologic and immunosuppressive therapies / Dr. Callen
4:00 PMTherapeutic decision making in transplant dermatology: management of high risk patients / Dr. Zwald
4:20 PMSentinel Lymph Node biopsy: just the facts, you decide / Dr. Johnson
5:00 PMConcluding remarks/additional questions from audience / All faculty